Cefpodoxime

🧮 Dose calculator

Acute otitis media · Regimen source: FDA Cefpodoxime susp. · Dosage and Administration

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefpodoxime susp. · Pregnancy - Teratogenic Effects:

  “Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg/kg/day (2 times the human dose based on mg/m 2 ) or to rabbits at doses up to 30 mg/kg/day (1 to 2 times the human dose based on mg/m 2 ).”

• 🤱 BreastfeedingDangerous / avoid

  Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Cefpodoxime susp. · Nursing Mothers:

  “Because of the potential for serious reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefpodoxime susp. · Pediatric Use:

  “Safety and efficacy in infants less than 2 months of age have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Cefpodoxime susp. · Geriatric Use:

  “No overall differences in effectiveness or safety were observed between the elderly and younger patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.